{"id": "qavmn0YAAAAJ", "citedby": 6787, "citedby5y": 6300, "hindex": 34, "hindex5y": 28, "i10index": 39, "i10index5y": 39, "coauthors": [{"id": "VqskH6cAAAAJ", "name": "Thomas F Gajewski", "affiliation": "Professor, University of Chicago"}, {"id": "_KmrkZ0AAAAJ", "name": "Riyue Bao", "affiliation": "Co-Director of CBS, UPMC Hillman Cancer Center; Res Associate Prof of Medicine, U of Pittsburgh"}, {"id": "Inp24jYAAAAJ", "name": "Jason John Luke", "affiliation": "UPMC / Univ. of Pittsburgh"}, {"id": "RsLTmdwAAAAJ", "name": "Randy F. Sweis", "affiliation": "University of Chicago"}, {"id": "Xcukp-0AAAAJ", "name": "Robbert Spaapen", "affiliation": "Sanquin Research"}, {"id": "PENhrsoAAAAJ", "name": "Katherine Fitzgerald", "affiliation": "Professor of Medicine, University of Massachusetts Medical School"}, {"id": "KDuhJOkAAAAJ", "name": "Ryan Duggan", "affiliation": "AbbVie, Inc."}, {"id": "9eVlp00AAAAJ", "name": "Jorge Andrade, Ph.D.", "affiliation": "Senior Director of Bioinformatics Kite Pharma"}, {"id": "u3xwhCUAAAAJ", "name": "Kyle Hernandez", "affiliation": "University of Chicago"}], "name": "Stefani Spranger", "affiliation": "Massachusetts Institute of Technology", "interests": ["Immunobiology", "Cancer immunology"], "cites_per_year": {"2010": 22, "2011": 39, "2012": 68, "2013": 104, "2014": 209, "2015": 397, "2016": 791, "2017": 1099, "2018": 1410, "2019": 1668, "2020": 898}, "publications": [{"bib": {"title": "Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:u-x6o8ySG0sC", "citedby": "1058"}, {"bib": {"title": "Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T cells", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:u5HHmVD_uO8C", "citedby": "1045"}, {"bib": {"title": "STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors", "year": "2014"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:d1gkVwhDpl0C", "citedby": "614"}, {"bib": {"title": "Loss of PTEN promotes resistance to T cell\u2013mediated immunotherapy", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:Tyk-4Ss8FVUC", "citedby": "547"}, {"bib": {"title": "Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy", "year": "2017"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:blknAaTinKkC", "citedby": "323"}, {"bib": {"title": "Mechanism of tumor rejection with doublets of CTLA-4", "year": "2014"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:rO6llkc54NcC", "citedby": "302"}, {"bib": {"title": "Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:9yKSN-GCB0IC", "citedby": "260"}, {"bib": {"title": "Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly \u2026", "year": "2014"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:2osOgNQ5qMEC", "citedby": "256"}, {"bib": {"title": "Density of immunogenic antigens does not explain the presence or absence of the T-cell\u2013inflamed tumor microenvironment in melanoma", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:4JMBOYKVnBMC", "citedby": "173"}, {"bib": {"title": "Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL", "year": "2012"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:qjMakFHDy7sC", "citedby": "172"}, {"bib": {"title": "Impact of oncogenic pathways on evasion of antitumour immune responses", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:ns9cj8rnVeAC", "citedby": "168"}, {"bib": {"title": "Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:_FxGoFyzp5QC", "citedby": "143"}, {"bib": {"title": "Innate immune signaling and regulation in cancer immunotherapy", "year": "2017"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:M3ejUd6NZC8C", "citedby": "131"}, {"bib": {"title": "Molecular drivers of the non\u2013T-cell-inflamed tumor microenvironment in urothelial bladder cancer", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:roLk4NBRz8UC", "citedby": "131"}, {"bib": {"title": "Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:LkGwnXOMwfcC", "citedby": "107"}, {"bib": {"title": "Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016; 6: 202\u2013216. doi: 10.1158/2159-8290"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:ldfaerwXgEUC", "citedby": "97"}, {"bib": {"title": "MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:IjCSPb-OGe4C", "citedby": "91"}, {"bib": {"title": "Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:zYLM7Y9cAGgC", "citedby": "90"}, {"bib": {"title": "Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity", "year": "2009"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:UeHWp8X0CEIC", "citedby": "86"}, {"bib": {"title": "Lymphatic vessels regulate immune microenvironments in human and murine melanoma", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:UebtZRa9Y70C", "citedby": "80"}, {"bib": {"title": "WNT/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:ZHo1McVdvXMC", "citedby": "78"}, {"bib": {"title": "Tumor-intrinsic oncogene pathways mediating immune avoidance", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:8k81kl-MbHgC", "citedby": "66"}, {"bib": {"title": "Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility", "year": "2009"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:Y0pCki6q_DkC", "citedby": "64"}, {"bib": {"title": "A new paradigm for tumor immune escape: \u03b2-catenin-driven immune exclusion", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:Se3iqnhoufwC", "citedby": "61"}, {"bib": {"title": "Rational combinations of immunotherapeutics that target discrete pathways", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:eQOLeE2rZwMC", "citedby": "61"}, {"bib": {"title": "Tumor and host factors controlling antitumor immunity and efficacy of cancer immunotherapy", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:3fE2CSJIrl8C", "citedby": "52"}, {"bib": {"title": "Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:W7OEmFMy1HYC", "citedby": "51"}, {"bib": {"title": "Cancer immunotherapy targets based on understanding the T cell-inflamed versus non-T cell-inflamed tumor microenvironment", "year": "2017"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:O3NaXMp0MMsC", "citedby": "50"}, {"bib": {"title": "TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo", "year": "2012"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:YsMSGLbcyi4C", "citedby": "44"}, {"bib": {"title": "Future perspectives in melanoma research. Meeting report from the \u201cMelanoma Bridge. Napoli, December 2nd-4th 2012\u201d", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:k_IJM867U9cC", "citedby": "43"}, {"bib": {"title": "Intratumoral CD8+ T-cell apoptosis is a major component of T-cell dysfunction and impedes antitumor immunity", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:BqipwSGYUEgC", "citedby": "42"}, {"bib": {"title": "NOD/scid IL-2Rg null mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo", "year": "2012"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:ufrVoPGSRksC", "citedby": "38"}, {"bib": {"title": "WNT signaling in cancer immunosurveillance", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:M05iB0D1s5AC", "citedby": "37"}, {"bib": {"title": "The CD6 scavenger receptor is differentially expressed on a CD56dim natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion", "year": "2011"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:WF5omc3nYNoC", "citedby": "37"}, {"bib": {"title": "Correlation of WNT/\u03b2-catenin pathway activation with immune exclusion across most human cancers.", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:5nxA0vEk-isC", "citedby": "28"}, {"bib": {"title": "Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:a0OBvERweLwC", "citedby": "17"}, {"bib": {"title": "Mechanisms of tumor cell\u2013intrinsic immune evasion", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:JV2RwH3_ST0C", "citedby": "13"}, {"bib": {"title": "Density of immunogenic antigens and presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma.", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:0EnyYjriUFMC", "citedby": "12"}, {"bib": {"title": "Melanoma-intrinsic \u03b2-catenin signaling prevents T cell infiltration and anti-tumor immunity", "year": "2014"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:hqOjcs7Dif8C", "citedby": "10"}, {"bib": {"title": "Synergistic combination of immunologic inhibitors for the treatment of cancer", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:QIV2ME_5wuYC", "citedby": "9"}, {"bib": {"title": "Tumor heterogeneity and tumor immunity: a chicken-and-egg problem", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:j3f4tGmQtD8C", "citedby": "9"}, {"bib": {"title": "Cutting edge: engineering active IKK\u03b2 in T cells drives tumor rejection", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:mVmsd5A6BfQC", "citedby": "9"}, {"bib": {"title": "Melanoma and immunotherapy bridge 2015", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:ULOm3_A8WrAC", "citedby": "8"}, {"bib": {"title": "Molecular drivers of the non-T cell-inflamed tumor microenvironment in urothelial bladder cancer.", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:maZDTaKrznsC", "citedby": "8"}, {"bib": {"title": "Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:yD5IFk8b50cC", "citedby": "7"}, {"bib": {"title": "A team effort: natural killer cells on the first leg of the tumor immunity relay race", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:35N4QoGY0k4C", "citedby": "7"}, {"bib": {"title": "Secondary resistance to immunotherapy associated with \u03b2-catenin pathway activation or PTEN loss in metastatic melanoma", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:xtRiw3GOFMkC", "citedby": "6"}, {"bib": {"title": "Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:cFHS6HbyZ2cC", "citedby": "6"}, {"bib": {"title": "Digital electronic audio player with cassette tape simulation feature and compatible with cassette tape players, and method therefore", "year": "2002"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:2P1L_qKh6hAC", "citedby": "5"}, {"bib": {"title": "Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:u9iWguZQMMsC", "citedby": "4"}, {"bib": {"title": "A tumor cell-intrinsic yin-yang determining immune evasion", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:70eg2SAEIzsC", "citedby": "4"}, {"bib": {"title": "31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:TQgYirikUcIC", "citedby": "4"}, {"bib": {"title": "MYC\u2014a thorn in the side of cancer immunity", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:_kc_bZDykSQC", "citedby": "4"}, {"bib": {"title": "Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:MXK_kJrjxJIC", "citedby": "3"}, {"bib": {"title": "Effect of melanoma intrinsic \u03b2-catenin signaling on immune exclusion and resistance to immunotherapies.", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:Zph67rFs4hoC", "citedby": "3"}, {"bib": {"title": "Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th\u20131 December 1st, 2018, Naples, Italy)", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:UxriW0iASnsC", "citedby": "2"}, {"bib": {"title": "Tissue site and the cancer immunity cycle", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:pyW8ca7W8N0C", "citedby": "2"}, {"bib": {"title": "The non-T-cell-inflamed tumor microenvironment: contributing factors and therapeutic solutions", "year": "2017"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:GnPB-g6toBAC", "citedby": "2"}, {"bib": {"title": "31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:ZeXyd9-uunAC", "citedby": "2"}, {"bib": {"title": "Formation of human neuroblastoma in mouse-human neural crest chimeras", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:OU6Ihb5iCvQC", "citedby": "1"}, {"bib": {"title": "Modulation of the immune microenvironment by tumor-intrinsic oncogenic signalingImpact of tumor cell\u2013intrinsic signaling on anti-tumor immunity", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:KxtntwgDAa4C", "citedby": "1"}, {"bib": {"title": "Perspectives in immunotherapy: meeting report from the \u201cImmunotherapy Bridge 2018\u201d(28\u201329 November, 2018, Naples, Italy)", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:CHSYGLWDkRkC", "citedby": "1"}, {"bib": {"title": "The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:YOwf2qJgpHMC", "citedby": "1"}, {"bib": {"title": "Therapeutic efficacy of combined blockade of CTLA-4+/-PD-L1+/-IDO is associated with re-activation of T cells directly within the tumor microenvironment", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:KlAtU1dfN6UC", "citedby": "1"}, {"bib": {"title": "Impact of tumor-resident DC on antitumor immunity.", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:p2g8aNsByqUC", "citedby": "0"}, {"bib": {"title": "Abstract IA04: Impact of tumor-resident DC on antitumor immunity", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:uWQEDVKXjbEC", "citedby": "0"}, {"bib": {"title": "CD36\u2014the Achilles\u2019 heel of T reg cells", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:SP6oXDckpogC", "citedby": "0"}, {"bib": {"title": "Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19", "year": "2020"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:XiSMed-E-HIC", "citedby": "0"}, {"bib": {"title": "Characterizing the anti-tumor immune response to an array of tumor cell lines expressing unique neoantigens", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "Novel dsRNA-sensing dendritic cells enhance anti-tumor immunity", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:P5F9QuxV20EC", "citedby": "0"}, {"bib": {"title": "Tissue site of tumor growth dictates anti-tumor immunity and response to checkpoint blockade", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:1sJd4Hv_s6UC", "citedby": "0"}, {"bib": {"title": "WNT Signaling in Cancer Immunosurveillance", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "Development of Human Neuroblastomas in Mouse-Human Neural Crest Chimeras", "year": "2019"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:3s1wT3WcHBgC", "citedby": "0"}, {"bib": {"title": "Synergistic combination of immunologic inhibitors for the treatment of cancer", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Abstract SY18-02: The relationship between Batf3-DC and antitumor T-cell responses", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:vV6vV6tmYwMC", "citedby": "0"}, {"bib": {"title": "Beta-catenin inhibitors in cancer immunotherapy", "year": "2018"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:NaGl4SEjCO4C", "citedby": "0"}, {"bib": {"title": "BATF3 DENDRITIC CELLS DRIVE ADOPTIVE EFFECTOR T-CELL TRAFFICKING", "year": "2017"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:lSLTfruPkqcC", "citedby": "0"}, {"bib": {"title": "CHARACTERIZATION OF NON-T CELL-INFLAMED BLADDER CANCER TO ENHANCE IMMUNOTHERAPY RESPONSE", "year": "2017"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:M3NEmzRMIkIC", "citedby": "0"}, {"bib": {"title": "Selective inhibition of MALT1 protease by phenothiazine derivatives", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:4TOpqqG69KYC", "citedby": "0"}, {"bib": {"title": "Abstract A104: T cell-mediated immune surveillance is inhibited by tumor-intrinsic signaling", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:qUcmZB5y_30C", "citedby": "0"}, {"bib": {"title": "Tumor-intrinsic beta-catenin signaling mediates tumor-immune avoidance", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:YFjsv_pBGBYC", "citedby": "0"}, {"bib": {"title": "Validation of activated molecular pathways in non-T cell-inflamed urothelial bladder cancer (UBC).", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:hMod-77fHWUC", "citedby": "0"}, {"bib": {"title": "Hier een korte vrije vertaling van een gedeelte uit het originele abstract, zie verder onderaan de foto en dit artikel", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:NhqRSupF_l8C", "citedby": "0"}, {"bib": {"title": "Abstract B154: Immune surveillance is thwarted by tumor-cell intrinsic \u03b2-catenin signaling", "year": "2016"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:qxL8FJ1GzNcC", "citedby": "0"}, {"bib": {"title": "Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or-PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:iH-uZ7U-co4C", "citedby": "0"}, {"bib": {"title": "Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:L8Ckcad2t8MC", "citedby": "0"}, {"bib": {"title": "Characterization of oncogenic pathways linked with T cell exclusion in urothelial bladder cancer", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:9ZlFYXVOiuMC", "citedby": "0"}, {"bib": {"title": "Erratum to STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors.[Immunity (2014), 41, 830-842, November 20].", "year": "2015"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:zA6iFVUQeVQC", "citedby": "0"}, {"bib": {"title": "Agonistic 4-1bb antibodies in combination with inhibitory antibodies against CTLA-4, PD-L1 or LAG-3 ACT on CD8+ T cells in the tumor microenvironment and synergize to promote \u2026", "year": "2014"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:R3hNpaxXUhUC", "citedby": "0"}, {"bib": {"title": "PHARMACOLOGIC INHIBITION OF MALT1 BY DISTINCT PHENOTHIAZINES FOR A TARGET-DIRECTED THERAPY OF ABC-DLBCL: 031", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:hFOr9nPyWt4C", "citedby": "0"}, {"bib": {"title": "HMMR-redirected adoptive T cell therapy for treatment of refractory acute myeloid leukemia in context of mismatched stem cell transplantation", "year": "2013"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "Synergistic Therapeutic Effect of Blocking Two Immune Inhibitory Pathways Concurrently in the Context of a Tolerogenic Tumor Microenvironment in vivo", "year": "2012"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:TFP_iSt0sucC", "citedby": "0"}, {"bib": {"title": "Tunneling nanotubes as a novel mechanism of intercellular communication between immune cells: P0219", "year": "2012"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:r0BpntZqJG4C", "citedby": "0"}, {"bib": {"title": "In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia", "year": "2011"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:hC7cP41nSMkC", "citedby": "0"}, {"bib": {"title": "MHC-RESTRICTED FRATRICIDE OF HUMAN LYMPHOCYTES EXPRESSING SURVIVIN-SPECIFIC TRANSGENIC T CELL RECEPTORS", "year": "2011"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:dhFuZR0502QC", "citedby": "0"}, {"bib": {"title": "In Vitro and in Vivo of Human Cell-based Immunotherapies for Acute Myeloid Leukemia", "year": "2011"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:4DMP91E08xMC", "citedby": "0"}, {"bib": {"title": "ESGCT 2010 Oral Presentations", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:RYcK_YlVTxYC", "citedby": "0"}, {"bib": {"title": "Fratricide of Recipient Lymphocytes Expressing Surviving-Specific Transgenic T Cell Receptors", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:7PzlFSSx8tAC", "citedby": "0"}, {"bib": {"title": "Enrichment of AML-Specific T Cells with Superior Functional Capacity and Transgenic Receptor Expression for Adoptive T Cell Transfer", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:aqlVkmm33-oC", "citedby": "0"}, {"bib": {"title": "MHC-Restricted Fratricide of Recipient Lymphocytes Expressing Transgenic T Cell Receptors Specific for the Apoptosis-Inhibitor Protein Survivin", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Introduction to Mouse Models", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:dfsIfKJdRG4C", "citedby": "0"}, {"bib": {"title": "Knockins and Knockouts", "year": "2010"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:4OULZ7Gr8RgC", "citedby": "0"}, {"bib": {"title": "High-Quality and High-Avidity T-cell Clones Specific for Tumor-associated Antigens and How to Find Them", "year": "2009"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:bEWYMUwI8FkC", "citedby": "0"}, {"bib": {"title": "The Synthetic Thiazoloquinolone Immunostimulatory Compound CL075 Serves as a Toll-like Receptor 7/8 Agonist and Substitutes for R848 to Produce Mature Human Monocyte-derived \u2026", "year": "2009"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "Influence on the Mutual Expression of Costimulatory Molecules on Renal Cell Carcinoma Lines Following Stable and Transient Transfection of CD80, CD86 and B7-H1", "year": "2008"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:RHpTSmoSYBkC", "citedby": "0"}, {"bib": {"title": "Isolating High-affinity T-cell Receptors for Adoptive Therapy of Tumors", "year": "2008"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:mB3voiENLucC", "citedby": "0"}, {"bib": {"title": "Characterization of a P-glycoprotein homolog in Schistosoma mansoni", "year": "2007"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:e5wmG9Sq2KIC", "citedby": "0"}, {"bib": {"title": "B\u00e1o c\u00e1o h\u00f3a h\u1ecdc:\" Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation\" pot"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:IWHjjKOFINEC", "citedby": "0"}, {"bib": {"title": "Loss of PTEN promotes resistance to T cell-mediated immunotherapy"}, "source": "citations", "id_citations": "qavmn0YAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}]}